1. A First‐in‐Patient, Multicenter, Double‐Blind, 2‐Arm, Placebo‐Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP‐499, in Chronic Kidney Disease. Issue 4 (11th February 2016) Authors: Sabounjian, LuAnn; Graham, Philip; Wu, Lijun; Braman, Virginia; Cheng, Changfu; Liu, Julie; Shipley, James; Neutel, Joel; Dao, Michael Journal: Clinical pharmacology in drug development Issue: Volume 5:Issue 4(2016:Jul./Aug.) Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Randomized Phase I Evaluation of CTP‐499, a Novel Deuterium‐Containing Drug Candidate for Diabetic Nephropathy1. Issue 1 (21st February 2013) Authors: Braman, Virginia; Graham, Philip; Cheng, Changfu; Turnquist, David; Harnett, Mark; Sabounjian, LuAnn; Shipley, James Journal: Clinical pharmacology in drug development Issue: Volume 2:Issue 1(2013:Jan.) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗